메뉴 건너뛰기




Volumn 25, Issue 5-6, 2008, Pages 510-514

Anti-inflammatory effect of sulodexide during acute peritonitis in rats

Author keywords

Inflammation; Lipopolysaccharide; Peritonitis; Tumor necrosis factor

Indexed keywords

ALBUMIN; DIALYSIS FLUID; ELASTASE; SULODEXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VESSEL DUE;

EID: 38849097250     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113011     Document Type: Article
Times cited : (26)

References (22)
  • 1
    • 0031938089 scopus 로고    scopus 로고
    • Pharmacological actions of sulodexide
    • Ofosu FA: Pharmacological actions of sulodexide. Semin Thromb Hemost 1998;24:127-138.
    • (1998) Semin Thromb Hemost , vol.24 , pp. 127-138
    • Ofosu, F.A.1
  • 2
    • 0026447391 scopus 로고
    • Sulodexide oral administration influences blood viscosity and fibrinolysis
    • Crepaldi G, Rossi A, Coscetti G, et al: Sulodexide oral administration influences blood viscosity and fibrinolysis. Drugs Exp Clin Res 1992;18:189-195.
    • (1992) Drugs Exp Clin Res , vol.18 , pp. 189-195
    • Crepaldi, G.1    Rossi, A.2    Coscetti, G.3
  • 3
    • 0025264190 scopus 로고
    • Double-blind trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use
    • Crepaldi G, Fellin R, Calabro A, et al: Double-blind trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use. Atherosclerosis 1990;81:233-243.
    • (1990) Atherosclerosis , vol.81 , pp. 233-243
    • Crepaldi, G.1    Fellin, R.2    Calabro, A.3
  • 4
    • 0021917821 scopus 로고
    • The effectiveness of glycosaminoglycans in peripheral vascular disease therapy: A clinical and experimental trial
    • Corsi C, Bocci L, Cipriani C, et al: The effectiveness of glycosaminoglycans in peripheral vascular disease therapy: a clinical and experimental trial. J Int Med Res 1985;13:40-47.
    • (1985) J Int Med Res , vol.13 , pp. 40-47
    • Corsi, C.1    Bocci, L.2    Cipriani, C.3
  • 5
    • 33644878779 scopus 로고    scopus 로고
    • Carotid plaque reduction after medical treatment
    • Stivali G, Cerroni F, Bianco P, et al: Carotid plaque reduction after medical treatment. Circulation 2005;112:e276-e277.
    • (2005) Circulation , vol.112
    • Stivali, G.1    Cerroni, F.2    Bianco, P.3
  • 6
    • 13244253793 scopus 로고    scopus 로고
    • Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis
    • Lauver DA, Booth EA, White AJ, et al: Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharmacol Exp Ther 2005;312:794-800.
    • (2005) J Pharmacol Exp Ther , vol.312 , pp. 794-800
    • Lauver, D.A.1    Booth, E.A.2    White, A.J.3
  • 7
    • 33646455615 scopus 로고    scopus 로고
    • In vivo antithrombotic synergy of oral heparin and arginine: Endothelial thromboresistance without changes in coagulation parameters
    • Daniels B, Linhardt RJ, Zhang F, et al: In vivo antithrombotic synergy of oral heparin and arginine: endothelial thromboresistance without changes in coagulation parameters. Thromb Haemost 2006;95:865-872.
    • (2006) Thromb Haemost , vol.95 , pp. 865-872
    • Daniels, B.1    Linhardt, R.J.2    Zhang, F.3
  • 8
    • 0026659040 scopus 로고
    • Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats
    • Gambaro G, Cavazzana AO, Luzi P, et al: Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 1992;29:285-291.
    • (1992) Kidney Int , vol.29 , pp. 285-291
    • Gambaro, G.1    Cavazzana, A.O.2    Luzi, P.3
  • 9
    • 29244469623 scopus 로고    scopus 로고
    • One year of oral sulodexide in the management of diabetic nephropathy
    • Achour A, Kacem M, Dibej K, et al: One year of oral sulodexide in the management of diabetic nephropathy. J Nephrol 2005;18:568-574.
    • (2005) J Nephrol , vol.18 , pp. 568-574
    • Achour, A.1    Kacem, M.2    Dibej, K.3
  • 10
    • 33746691250 scopus 로고    scopus 로고
    • The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy
    • Abaterusso C, Gambaro G: The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. Treat Endocrinol 2006;5:211-222.
    • (2006) Treat Endocrinol , vol.5 , pp. 211-222
    • Abaterusso, C.1    Gambaro, G.2
  • 11
    • 0032918585 scopus 로고    scopus 로고
    • Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis
    • Fracasso A, Baggio B, Ossi E, et al: Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis. Am J Kidney Dis 1999;33:105-110.
    • (1999) Am J Kidney Dis , vol.33 , pp. 105-110
    • Fracasso, A.1    Baggio, B.2    Ossi, E.3
  • 12
    • 0029148402 scopus 로고
    • Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis
    • Bazzato G, Fracasso A, Gambaro G, Baggio B: Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis. Lancet 1995;346:740-741.
    • (1995) Lancet , vol.346 , pp. 740-741
    • Bazzato, G.1    Fracasso, A.2    Gambaro, G.3    Baggio, B.4
  • 13
    • 0348044485 scopus 로고    scopus 로고
    • Effect of oral treatment with the glycosaminoglycan sulodexide on peritoneal transport in CAPD patients
    • Fracasso A, Baggio B, Masiero M, et al: Effect of oral treatment with the glycosaminoglycan sulodexide on peritoneal transport in CAPD patients. Perit Dial Int 2003;23:595-599.
    • (2003) Perit Dial Int , vol.23 , pp. 595-599
    • Fracasso, A.1    Baggio, B.2    Masiero, M.3
  • 14
    • 0027499988 scopus 로고
    • Suppressive effects of hyaluronic acid on elastase release from rat peritoneal leukocytes
    • Akatsuka M, Yamamoto Y, Tobetto K, et al: Suppressive effects of hyaluronic acid on elastase release from rat peritoneal leukocytes. J Pharm Pharmacol 1993;45:110-114.
    • (1993) J Pharm Pharmacol , vol.45 , pp. 110-114
    • Akatsuka, M.1    Yamamoto, Y.2    Tobetto, K.3
  • 15
    • 0036413438 scopus 로고    scopus 로고
    • The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter
    • Pecoits-Filho R, Lindholm B, Stenvinkel P: The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 2002;17(suppl 11):28-31.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 11 , pp. 28-31
    • Pecoits-Filho, R.1    Lindholm, B.2    Stenvinkel, P.3
  • 16
    • 33745544967 scopus 로고    scopus 로고
    • Malnutrition-inflammation- atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients
    • Tonbul HZ, Demir M, Altintepe L, et al: Malnutrition-inflammation- atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail 2006;28:287-294.
    • (2006) Ren Fail , vol.28 , pp. 287-294
    • Tonbul, H.Z.1    Demir, M.2    Altintepe, L.3
  • 17
    • 0028365467 scopus 로고
    • Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats
    • Brȩborowicz A, Wieczorowska K, Martis L, Oreopoulos DG: Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats. Nephron 1994;67:346-350.
    • (1994) Nephron , vol.67 , pp. 346-350
    • Brȩborowicz, A.1    Wieczorowska, K.2    Martis, L.3    Oreopoulos, D.G.4
  • 18
    • 0006360236 scopus 로고    scopus 로고
    • Dialysis solution containing hyaluronan: Effect on peritoneal permeability and inflammation in rats
    • Połubinska A, Pawlaczyk K, Kuzlan-Pawlaczyk M, et al: Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats. Kidney Int 2000;57:1182-1189.
    • (2000) Kidney Int , vol.57 , pp. 1182-1189
    • Połubinska, A.1    Pawlaczyk, K.2    Kuzlan-Pawlaczyk, M.3
  • 19
    • 0035571598 scopus 로고    scopus 로고
    • Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid - experimental study in rats
    • Brȩborowicz A, Pawlaczyk-Kuzlan M, Pawlaczyk K, et al: Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid - experimental study in rats. Perit Dial Int 2001;21(suppl 3):s316-s318.
    • (2001) Perit Dial Int , vol.21 , Issue.SUPPL. 3
    • Brȩborowicz, A.1    Pawlaczyk-Kuzlan, M.2    Pawlaczyk, K.3
  • 20
    • 21344463080 scopus 로고    scopus 로고
    • Intraperitoneal heparin ameliorates the systemic inflammatory response in peritoneal dialysis patients
    • Sjoland JA, Pedersen RS, Jespersen J, Gram J: Intraperitoneal heparin ameliorates the systemic inflammatory response in peritoneal dialysis patients. Nephron Clin Pract 2005;100:c105-c110.
    • (2005) Nephron Clin Pract , vol.100
    • Sjoland, J.A.1    Pedersen, R.S.2    Jespersen, J.3    Gram, J.4
  • 21
    • 0035123653 scopus 로고    scopus 로고
    • Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats
    • Brȩborowicz A, Połubinska A, Moberly J, et al: Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats. Am J Kidney Dis 2001;37:594-600.
    • (2001) Am J Kidney Dis , vol.37 , pp. 594-600
    • Brȩborowicz, A.1    Połubinska, A.2    Moberly, J.3
  • 22
    • 0036257599 scopus 로고    scopus 로고
    • Macrophages and the pathogenesis of COPD
    • Tetley TD: Macrophages and the pathogenesis of COPD. Chest 2002;121(suppl):156S-159S.
    • (2002) Chest , vol.121 , Issue.SUPPL.
    • Tetley, T.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.